SARAH SLATON: Open Payments
NPI 1841078128 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $651 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $147 |
| Janssen Pharmaceuticals, Inc | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Almatica Pharma LLC | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Luye Pharma (USA) Ltd. | 1 | $24 |
| Biogen, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, SPRAVATO, HETLIOZ, LOREEV XR, CAPLYTA, ERZOFRI EXTENDED-RELEASE, ZURZUVAE, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
